LIGAND PHARMACEUTICALS INC — Investor Relations & Filings
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-18 | English | |
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-08 | English | |
| 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46385520 | DEFA14A | 2026-05-18 | English | ||
| 46385526 | 8-K | 2026-05-18 | English | ||
| 46155763 | 10-Q | 2026-05-08 | English | ||
| 42834703 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | ||
| 46155787 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155789 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155782 | 8-K | 2026-04-30 | English | ||
| 46155792 | DEFA14A | 2026-04-27 | English | ||
| 37461463 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-27 | English | ||
| 46155795 | ARS | 2026-04-21 | English | ||
| 46155796 | DEFA14A | 2026-04-21 | English | ||
| 34907767 | DEF 14A - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-21 | English | ||
| 33067636 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067397 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067331 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
Market data
Market data not available
Price history
Peer group · Other financial service activities n.e.c., except insurance and pension funding activities
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bluerock Acquisition Corp.
A Special Purpose Acquisition Company (SPAC) focused on exe…
|
BLRK | CA | Financial and insurance activit… |
|
Blue Water Acquisition Corp. III
A special purpose acquisition company focused on merging wi…
|
BLUW | US | Financial and insurance activit… |
|
BLU LABEL UNLIMITED GROUP LIMITED
Digital distribution of prepaid products, virtual merchandi…
|
BLU | ZA | Financial and insurance activit… |
|
Bluspring Enterprises Limited
Provides investment management, strategic capital solutions…
|
BLUSPRING | IN | Financial and insurance activit… |
|
BOC International (China) Co., Ltd.
Offers investment banking, securities brokerage, and asset …
|
601696 | CN | Financial and insurance activit… |
|
BOCOM International Holdings Company Limited
Integrated securities and financial services platform of Ba…
|
3329 | HK | Financial and insurance activit… |
|
BOMBAY OXYGEN INVESTMENTS LIMITED
An NBFC focused on investing in and trading equity shares, …
|
509470 | IN | Financial and insurance activit… |
|
BOOKOOK SECURITIES CO.,LTD
Financial services provider offering brokerage, dealing, an…
|
001270 | KR | Financial and insurance activit… |
|
BOSTON COMMERCE LIMITED
Engages in trading, investment management, and the provisio…
|
531458 | IN | Financial and insurance activit… |
|
Bourse Direct
Online brokerage offering trading, savings, and financial i…
|
BSD | FR | Financial and insurance activit… |
LIGAND PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31289/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31289 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31289 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31289 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31289}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LIGAND PHARMACEUTICALS INC (id: 31289)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.